Eder, Michael opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Eder, Michael

Patent Number:
Title:
Protein Purification Method
Opposition Date:
Feb 9, 2018
Patent Number:
Title:
Pharmaceutical Oral Dosage Forms Comprising Dabigatran Etexilate And Its Pharmaceutically Acceptable Salts
Opposition Date:
Jan 19, 2018

Want to track Eder, Michael?

Feel free to send us a message here and we will get back to you